Prossimo Advisors LLC Sells 42 Shares of Intuitive Surgical, Inc. (NASDAQ:ISRG)

Prossimo Advisors LLC reduced its stake in Intuitive Surgical, Inc. (NASDAQ:ISRG) by 8.6% during the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 447 shares of the medical equipment provider’s stock after selling 42 shares during the period. Prossimo Advisors LLC’s holdings in Intuitive Surgical were worth $233,000 at the end of the most recent reporting period.

Several other institutional investors and hedge funds have also recently modified their holdings of the stock. Berbice Capital Management LLC bought a new stake in shares of Intuitive Surgical in the 4th quarter valued at about $26,000. Godsey & Gibb Inc. increased its holdings in Intuitive Surgical by 140.0% during the third quarter. Godsey & Gibb Inc. now owns 60 shares of the medical equipment provider’s stock valued at $29,000 after buying an additional 35 shares during the period. MidAtlantic Capital Management Inc. bought a new position in Intuitive Surgical in the third quarter worth approximately $33,000. Decker Retirement Planning Inc. purchased a new stake in Intuitive Surgical during the fourth quarter worth $36,000. Finally, Sierra Ocean LLC bought a new stake in Intuitive Surgical during the 4th quarter valued at $40,000. Institutional investors own 83.64% of the company’s stock.

Wall Street Analysts Forecast Growth

ISRG has been the subject of a number of analyst reports. Stifel Nicolaus upped their price objective on Intuitive Surgical from $525.00 to $610.00 and gave the stock a “buy” rating in a research note on Thursday, December 5th. Wells Fargo & Company raised their price target on shares of Intuitive Surgical from $630.00 to $687.00 and gave the company an “overweight” rating in a report on Friday, January 24th. Jefferies Financial Group lifted their price objective on shares of Intuitive Surgical from $475.00 to $575.00 in a research report on Monday, January 27th. Leerink Partners upped their price target on Intuitive Surgical from $490.00 to $548.00 in a research report on Monday, January 27th. Finally, Barclays upped their target price on Intuitive Surgical from $610.00 to $674.00 in a research report on Monday, January 27th. One analyst has rated the stock with a sell rating, five have given a hold rating and sixteen have given a buy rating to the company’s stock. Based on data from MarketBeat, the company currently has a consensus rating of “Moderate Buy” and a consensus price target of $613.10.

Insider Activity at Intuitive Surgical

In other news, EVP Robert Desantis sold 376 shares of the firm’s stock in a transaction that occurred on Friday, November 29th. The stock was sold at an average price of $539.00, for a total value of $202,664.00. Following the transaction, the executive vice president now owns 5,506 shares in the company, valued at $2,967,734. This trade represents a 6.39 % decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is available through this link. Also, CFO Jamie Samath sold 108 shares of the business’s stock in a transaction that occurred on Tuesday, November 26th. The stock was sold at an average price of $542.06, for a total value of $58,542.48. Following the sale, the chief financial officer now owns 8,757 shares of the company’s stock, valued at $4,746,819.42. The trade was a 1.22 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders sold a total of 6,348 shares of company stock worth $3,587,582 in the last 90 days. Corporate insiders own 0.90% of the company’s stock.

Intuitive Surgical Price Performance

ISRG opened at $601.17 on Wednesday. The firm has a fifty day moving average price of $561.88 and a 200 day moving average price of $522.27. Intuitive Surgical, Inc. has a 1 year low of $364.17 and a 1 year high of $616.00. The stock has a market cap of $214.12 billion, a P/E ratio of 93.79, a P/E/G ratio of 5.67 and a beta of 1.39.

Intuitive Surgical Company Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.